Adenovirus types 5 and 35 seroprevalence in AIDS risk groups supports type 35 as a vaccine vector
暂无分享,去创建一个
B. Berkhout | S. Kostense | G. Weverling | M. Havenga | R. Vogels | J. Goudsmit | W. Koudstaal | M. Bakker | M. Sprangers | Germaine Penders | N. Helmus